+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are studying adults newly diagnosed with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancers who are starting systemic cancer treatments such as chemotherapy or immune checkpoint inhibitors. The purpose is to understand how cannabis and cannabinoid use relates to cancer-related symptoms over one year. This observational study enrolls 2000 participants to explore these associations in community oncology settings. Participants do not receive any experimental treatments but complete surveys and have their medical records reviewed. Assessments occur monthly for up to 12 months, capturing cannabis use, perceived benefits and harms, and adverse effects alongside symptom tracking. There is an optional sub-study for some participants receiving immune checkpoint inhibitors at specific cancer centers. During the study, participants complete monthly surveys either online at home, in clinic, or other locations, and their medical records are reviewed for treatment and symptom information. Researchers measure cancer-related symptoms and cannabis use patterns over time. The study monitors participants for up to one year to evaluate symptom changes and cannabis-related effects, with no intervention administered by the study team.

Age: 18Years +All Genders
491 locations
E

Actively Recruiting

Healthy Volunteer

This trial is studying advanced practice providers APPs who work in cancer care but may not regularly participate in clinical research at community oncology sites. It evaluates whether a mentorship and education program called COACH-APP can improve APPs confidence in their ability to engage in clinical research, known as research self-efficacy. The study aims to see if this program helps APPs integrate more meaningfully into research teams and potentially improves patient care and access to clinical trials. Participants are divided into groups where one receives the COACH-APP intervention, which includes completing a 6-module clinical research workshop over 2 hours, receiving a clinical trials research manual, and participating in five mentoring sessions lasting 15-60 minutes over 12 months. The comparison group receives only access to the workshop and manual for 12 months. Additionally, mentors providing the COACH-APP mentorship and selected research care team members participate in qualitative interviews to assess the interventions impact. During the study, participants complete surveys and interviews to measure changes in research self-efficacy, engagement with the National Cancer Institutes community oncology research program, integration into research care teams, and practice-level study activity over 12 to 24 months. The trial also evaluates the feasibility, acceptability, and appropriateness of the COACH-APP program. Participation involves training sessions, mentoring, surveys, and interviews over a 12-month period with follow-up assessments extending up to 24 months.

Age: 18Years +All GendersPhase Not Applicable
44 locations
T

Actively Recruiting

Researchers are conducting a Hybrid Type 1 cluster-randomized trial in community oncology practice sites to evaluate an intervention aimed at improving the referral and enrollment of Black and Latino cancer patients into National Cancer Institute-supported clinical trials. This study focuses on measuring how effective the intervention is in increasing patient referrals and accrual while also assessing awareness and knowledge of clinical trials among participants and providers. The trial also includes evaluation of implementation factors and plans for dissemination of the intervention to other community oncology sites and networks. The intervention being studied combines clinical trial navigators with research literacy tools in a SUPPORT toolkit, which includes a website and navigator interaction. Participants are assigned to either usual care or the intervention group receiving the SUPPORT toolkit. This study uses a cluster-randomized, parallel design enrolling approximately 500 Black and Latino cancer patients from community oncology sites affiliated with the NCORP network. Participants will be involved for at least 12 months during which referral and accrual to clinical trials are measured as primary and secondary outcomes. The study also evaluates participant and provider awareness and knowledge of clinical trials. Data will be collected through site evaluations and participant interactions. The trial runs from April 2025 through March 2028 with a primary completion date in August 2027.

Age: 18Years +All GendersPhase Not Applicable
67 locations